438 related articles for article (PubMed ID: 28912625)
1. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
Hegedüs K; Kárpáti J; Iljicsov A; Simó M
Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
[TBL] [Abstract][Full Text] [Related]
3. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
5. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
6. Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Kraemer M; Herold M; Uekermann J; Kis B; Daum I; Wiltfang J; Berlit P; Diehl RR; Abdel-Hamid M
J Neuropsychol; 2013 Mar; 7(1):91-106. PubMed ID: 23126275
[TBL] [Abstract][Full Text] [Related]
7. Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis.
Kraemer M; Herold M; Uekermann J; Kis B; Wiltfang J; Daum I; Dziobek I; Berlit P; Diehl RR; Abdel-Hamid M
Clin Neurol Neurosurg; 2013 Jul; 115(7):1016-22. PubMed ID: 23199520
[TBL] [Abstract][Full Text] [Related]
8. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
9. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
[TBL] [Abstract][Full Text] [Related]
10. The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
Cabeça HLS; Rocha LC; Sabbá AF; Tomás AM; Bento-Torres NVO; Anthony DC; Diniz CWP
BMC Neurol; 2018 Sep; 18(1):140. PubMed ID: 30200902
[TBL] [Abstract][Full Text] [Related]
11. Cognition in early relapsing-remitting multiple sclerosis: consequences may be relative to working memory.
Berrigan LI; Lefevre JA; Rees LM; Berard J; Freedman MS; Walker LA
J Int Neuropsychol Soc; 2013 Sep; 19(8):938-49. PubMed ID: 23866100
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.
Messinis L; Nasios G; Kosmidis MH; Zampakis P; Malefaki S; Ntoskou K; Nousia A; Bakirtzis C; Grigoriadis N; Gourzis P; Papathanasopoulos P
Behav Neurol; 2017; 2017():5919841. PubMed ID: 29463950
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment among different clinical courses of multiple sclerosis.
Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
15. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.
Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U
Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074
[TBL] [Abstract][Full Text] [Related]
16. New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
Wybrecht D; Reuter F; Pariollaud F; Zaaraoui W; Le Troter A; Rico A; Confort-Gouny S; Soulier E; Guye M; Maarouf A; Ranjeva JP; Pelletier J; Audoin B
PLoS One; 2017; 12(11):e0184650. PubMed ID: 29149177
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
19. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
[TBL] [Abstract][Full Text] [Related]
20. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]